Bilateral Erector Spinae Plane Block for Management of Acute Postoperative Pain After Pediatric Cardiac Surgeries Through a Midline Sternotomy
1 other identifier
interventional
75
0 countries
N/A
Brief Summary
Many analgesic modalities have been investigated in pediatrics. The analgesic efficacy of bilateral ultrasound-guided erector spinae plane block in pediatric patients undergoing open midline sternotomy will be examined. Methods: 60 patients aged 3- 12 years will be randomly assigned into two groups: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain was assessed using Modified Objective Pain Scores (MOPS) which will be evaluated at 0, 1, 2, 4, 6, 8, 10, and 12 hours after extubation, total consumption of intraoperative fentanyl (1µg/kg IV in case of inadequate analgesia), time to first rescue analgesic administration and postoperative paracetamol consumption will be recorded over the first 24 hours postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2021
CompletedFirst Posted
Study publicly available on registry
December 2, 2021
CompletedStudy Start
First participant enrolled
February 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2022
CompletedFebruary 1, 2022
December 1, 2021
2 months
November 6, 2021
January 31, 2022
Conditions
Outcome Measures
Primary Outcomes (7)
Modified Objective Pain Score (MOPS)0
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
at immediately post extubation.
Modified Objective Pain Score (MOPS)1
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
at1 hour post extubation.
Modified Objective Pain Score (MOPS)2
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
at 2 hour post extubation.
Modified Objective Pain Score (MOPS)3
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
at 4 hour post extubation.
Modified Objective Pain Score (MOPS)4
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
at 6 hour post extubation.
Modified Objective Pain Score (MOPS)5
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
at 8 hour post extubation.
Modified Objective Pain Score (MOPS)6
A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest
at 12 hour post extubation.
Study Arms (2)
control group
PLACEBO COMPARATORwill receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side.
Erector spinae plane block group
ACTIVE COMPARATORwill receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg.
Interventions
Ultrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions by a high frequency (6-13 MHz) linear ultrasound transducer
IV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia.
Eligibility Criteria
You may qualify if:
- children undergoing cardiac surgical procedures through midline sternotomy
You may not qualify if:
- The patients with preoperative ejection fraction \<35%
- allergic to the amide type of local anesthetics (LA)
- preoperative inotropic support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Patients unaware and care giver were unaware about what is injected inthe catheters
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
November 6, 2021
First Posted
December 2, 2021
Study Start
February 5, 2022
Primary Completion
March 30, 2022
Study Completion
March 30, 2022
Last Updated
February 1, 2022
Record last verified: 2021-12